Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Cholebine
2. Mci-196
1. 95522-45-5
2. Colestimide
3. Colestilan Chloride
4. 2-(chloromethyl)oxirane;2-methyl-1h-imidazole
5. Cholebine
6. 1h-imidazole, 2-methyl-, Polymer With (chloromethyl)oxiraneother Ca Index Names:oxirane, (chloromethyl)-, Polymer With 2-methyl-1h-imidazole
7. Colestilan [inn]
8. Unii-vsi302rysr
9. Colestilan Chloride [usan]
10. Epichlorohydrin-2-methylimidazole Copolymer
11. Mci 196
12. Mci-196
13. 2-(chloromethyl)oxirane; 2-methyl-1h-imidazole
14. Cholebine (japan)
15. Vsi302rysr
16. Schembl1649186
17. 2-methylimidazole Polymer With 1-chloro-2,3-epoxypropane
18. Dtxsid40914950
19. Q4117076
20. 2-(chloromethyl)oxirane--2-methyl-1h-imidazole (1/1)
21. 1h-imidazole, 2-methyl-, Polymer With (chloromethyl)oxirane
22. Oxirane, (chloromethyl)-, Polymer With 2-methyl-1h-imidazole
Molecular Weight | 174.63 g/mol |
---|---|
Molecular Formula | C7H11ClN2O |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 1 |
Exact Mass | 174.0559907 g/mol |
Monoisotopic Mass | 174.0559907 g/mol |
Topological Polar Surface Area | 41.2 Ų |
Heavy Atom Count | 11 |
Formal Charge | 0 |
Complexity | 82.7 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Treatment of hyperphosphataemia in adult patients with chronic kidney disease stage 5 receiving haemodialysis or peritoneal dialysis.
Treatment of hyperphosphataemia
V03AE
V - Various
V03 - All other therapeutic products
V03A - All other therapeutic products
V03AE - Drugs for treatment of hyperkalemia and hyperphosphatemia
V03AE06 - Colestilan
Market Place
ABOUT THIS PAGE
47
PharmaCompass offers a list of Cholebine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cholebine manufacturer or Cholebine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cholebine manufacturer or Cholebine supplier.
PharmaCompass also assists you with knowing the Cholebine API Price utilized in the formulation of products. Cholebine API Price is not always fixed or binding as the Cholebine Price is obtained through a variety of data sources. The Cholebine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Epichlorohydrin-2-methylimidazole copolymer manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Epichlorohydrin-2-methylimidazole copolymer, including repackagers and relabelers. The FDA regulates Epichlorohydrin-2-methylimidazole copolymer manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Epichlorohydrin-2-methylimidazole copolymer API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Epichlorohydrin-2-methylimidazole copolymer supplier is an individual or a company that provides Epichlorohydrin-2-methylimidazole copolymer active pharmaceutical ingredient (API) or Epichlorohydrin-2-methylimidazole copolymer finished formulations upon request. The Epichlorohydrin-2-methylimidazole copolymer suppliers may include Epichlorohydrin-2-methylimidazole copolymer API manufacturers, exporters, distributors and traders.
click here to find a list of Epichlorohydrin-2-methylimidazole copolymer suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Epichlorohydrin-2-methylimidazole copolymer DMF (Drug Master File) is a document detailing the whole manufacturing process of Epichlorohydrin-2-methylimidazole copolymer active pharmaceutical ingredient (API) in detail. Different forms of Epichlorohydrin-2-methylimidazole copolymer DMFs exist exist since differing nations have different regulations, such as Epichlorohydrin-2-methylimidazole copolymer USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Epichlorohydrin-2-methylimidazole copolymer DMF submitted to regulatory agencies in the US is known as a USDMF. Epichlorohydrin-2-methylimidazole copolymer USDMF includes data on Epichlorohydrin-2-methylimidazole copolymer's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Epichlorohydrin-2-methylimidazole copolymer USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Epichlorohydrin-2-methylimidazole copolymer suppliers with USDMF on PharmaCompass.
Epichlorohydrin-2-methylimidazole copolymer Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Epichlorohydrin-2-methylimidazole copolymer GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Epichlorohydrin-2-methylimidazole copolymer GMP manufacturer or Epichlorohydrin-2-methylimidazole copolymer GMP API supplier for your needs.
A Epichlorohydrin-2-methylimidazole copolymer CoA (Certificate of Analysis) is a formal document that attests to Epichlorohydrin-2-methylimidazole copolymer's compliance with Epichlorohydrin-2-methylimidazole copolymer specifications and serves as a tool for batch-level quality control.
Epichlorohydrin-2-methylimidazole copolymer CoA mostly includes findings from lab analyses of a specific batch. For each Epichlorohydrin-2-methylimidazole copolymer CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Epichlorohydrin-2-methylimidazole copolymer may be tested according to a variety of international standards, such as European Pharmacopoeia (Epichlorohydrin-2-methylimidazole copolymer EP), Epichlorohydrin-2-methylimidazole copolymer JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Epichlorohydrin-2-methylimidazole copolymer USP).